Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001682220-22-000001
Filing Date
2022-09-14
Accepted
2022-09-13 17:53:10
Documents
1
Effectiveness Date
2022-09-14
Items
Item 06b:
Item 4a5:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11872
  Complete submission text file 0001682220-22-000001.txt   13018
Mailing Address 100 OVERLOOK CENTER, 2ND FLOOR PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER, 2ND FLOOR PRINCETON NJ 08540 215-554-3530
Eleison Pharmaceuticals Inc (Filer) CIK: 0001880047 (see all company filings)

EIN.: 454373885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-458772 | Film No.: 221241666
SIC: 2834 Pharmaceutical Preparations